| Pancreatic cancer ranks fourth among cancers as a leading cause of death. More than 37,000 new cases will be diagnosed in the United States this year, and an estimated 33,370 deaths will result. The average life expectancy of a newly diagnosed pancreatic cancer patient is about four months; the 5-year survival rate is only about 4%. |
Ras Therapeutics aspires to bring new hope to sufferers of pancreatic and other cancers with new treatment options and the advancement of clinical trials methodologies. |
